Clinical Characteristics and Microbiological Profile of Oral Candidiasis among HIV-Positive Patients in Indonesia: A Literature Review
Downloads
Background: As the country with the highest identified active cases of HIV/AIDS across Southeast Asia, Indonesia faces a massive challenge in providing adequate antiretroviral therapy (ART) coverage to prevent disease progression and mortality. Oral candidiasis (OC) is the most frequently identified oral manifestation of HIV infection and represents the degree of immunosuppression, treatment failure, and prognosis among people living with HIV/AIDS. Demographic characteristics, clinical types, and causative pathogens of OC vary between different geographical and socioeconomic settings. Hence, the role of oral candidiasis is crucial in developing effective strategies to address the HIV-related burden in Indonesia. Review: This literature review evaluated 11 descriptive studies conducted across eight major cities in Indonesia, comprising 764 HIV-positive patients diagnosed with OC. Most affected individuals were male and exhibited advanced immunosuppression, with the majority presenting CD4+ counts below 200 cells/mm³. Six clinical variants of OC were identified, with pseudomembranous candidiasis being the predominant form, followed by angular cheilitis, erythematous candidiasis, hyperplastic candidiasis, and sporadic cases of atrophic candidiasis and denture stomatitis. Microbiological findings showed Candida albicans as the leading etiologic species; however, non-albicans Candida (NAC)—particularly C. krusei, C. glabrata, and C. tropicalis—demonstrated notable prevalence, including mixed colonization with C. albicans. The rise of NAC species highlights concerns regarding antifungal resistance in the ART era. Conclusion: Oral candidiasis serves as an important clinical finding among patients living with HIV/AIDS, and its appropriate management is necessary not only to prevent further complications but also to mitigate the recent development of antifungal resistance.
Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002 Aug; 78(922): 455–9.
Taylor M, Raja A. Oral Candidiasis [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://pubmed.ncbi.nlm.nih.gov/31424866/
Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J fungi (Basel, Switzerland) 2017 Oct;3(4).
Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral Candidiasis: A Disease of Opportunity. J fungi (Basel, Switzerland) 2020 Jan; 6(1).
Shekatkar M, Kheur S, Gupta AA, Arora A, Raj AT, Patil S, et al. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy. Dis Mon 2021 Sep;67(9):101169.
Taverne-Ghadwal L, Kuhns M, Buhl T, Schulze MH, Mbaitolum WJ, Kersch L, et al. Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era. Front Microbiol 2022 Feb 17;13:844069.
Berberi A, Noujeim Z, Aoun G. Epidemiology of Oropharyngeal Candidiasis in Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients and CD4+ Counts. J Int oral Heal J 2015 Mar; 7(3): 20–3.
Cassone A, Cauda R. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS 2012 Jul; 26(12):1457–72.
Sharma G, Oberoi SS, Vohra P, Nagpal A. Oral manifestations of HIV/AIDS in Asia: Systematic review and future research guidelines. J Clin Exp Dent 2015 Jul;7(3):e419-27.
Soebadi B, Parmadiati A, Hendarti H, Radithia D, Savitri E D. The Prevalence of Oral Manifestation in Transgenders with HIV/AIDS in Surabaya, East Java, Indonesia. Indian J Public Heal Res Dev 2019 Jan 1;10:577.
Lu SY. Oral candidosis: Pathophysiology and best practice for diagnosis, classification, and successful management. J Fungi 2021;7(7).
Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol 2011 Jan;3.
Spalanzani RN, Mattos K, Marques LI, Barros PFD, Pereira PIP, Paniago AMM, et al. Clinical and laboratorial features of oral candidiasis in HIV-positive patients. Rev Soc Bras Med Trop 2018;51(3):352–6.
Maheshwari M, Kaur R, Chadha S. Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India. J Pathog 2016;2016:6204804.
Ribeiro Ribeiro AL, de Alencar Menezes TO, de Melo Alves-Junior S, de Menezes SAF, Marques-da-Silva SH, Rosário Vallinoto AC. Oral carriage of Candida species in HIV-infected patients during highly active antiretroviral therapy (HAART) in Belém, Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120(1):29–33.
Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, et al. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Lett Appl Microbiol 2018 Oct 1;67(4):392–9.
Jamil F. Profil kandidiasis oral pada penderita AIDS Di RSU. Dr. Zainoel Abidin Banda Aceh. J Kedokt Syiah Kuala 2009;10(2).
Sofro M, Angita I, Isbandrio B. Karakteristik Pasien HIV/AIDS dengan Kandidiasis Orofaringeal di RSUP Dr . Kariadi Semarang. Medica Hosp J Clin Med 2013 Aug 22;1.
Suryana K, Suharsono H, Antara IGPJ. Factors Associated with Oral Candidiasis in People Living with HIV/AIDS: A Case Control Study. HIV AIDS (Auckl) 2020;12:33–9.
Sumintarti S, Rasdiana A. Manifestasi klinis tipe kandidiasis oral pada penderita AIDS di Rumah Sakit Dr Wahidin Sudirohusodo, Makassar (Clinical manifestations of oral candidiasis types in AIDS patients at Dr Wahidin Sudirohusodo Hospital, Makassar). J Dentomaxillofacial Sci 2014;13(3):186–9.
Walangare T, Hidayat T, Basuki S. Profil Spesies Candida pada Pasien Kandidiasis Oral dengan Infeksi HIV & AIDS. Berk Ilmu Kesehat Kulit dan Kelamin 2014;26(1):29–35.
Kusuma AL, Prakoeswa FRS, Pramuningtyas R. Hubungan Kadar CD4 Dengan Kejadian Kandidiasis Oral Pada Penderita Hiv/Aids Di Rsud Moewardi [Internet]. Universitas Muhammadiyah Surakarta; 2014. Available from: https://eprints.ums.ac.id/29228/9/NASKAH_PUBLIKASI.pdf
Nugraha AP, Ernawati DS, Parmadiati AE, Soebadi B, Triyono EA, Prasetyo RA, et al. Prevalence of candida species in oral candidiasis and correlation with CD4+ count in HIV/AIDS patients at Surabaya, Indonesia. J Int Dent Med Res 2018;11(1):81–5.
Mensana MP, Ernawati DS, Nugraha AP, Soebadi B, Triyono EA, Husada D, et al. Oral candidiasis profile of the Indonesian HIV-infected pediatric patients at UPIPI Dr. Soetomo General Hospital, Surabaya, Indonesia. HIV & AIDS Rev Int J HIV-Related Probl 2018;17(4):272–7.
Putranti A, Asmarawati TP, Rachman BE, Hadi U, Nasronudin. Oral candidiasis as clinical manifestation of HIV/AIDS in Airlangga University hospital patients. IOP Conf Ser Earth Environ Sci 2018;125(1):012063.
Mardhatillah AN, Tjahajawati S, Sufiawati I. Karakteristik pasien, jenis terapi, dan tingkat imunosupresi hasil terapi pada wanita penderita HIV/AIDS dengan kandidiasis oral Patient characteristics, type of therapy, and immunosuppression level of therapy outcomes in HIV/AIDS female patients with ora. J Kedokt Gigi Univ Padjadjaran 2020; 32(2):150–5.
Murtiastutik D, Prakoeswa CRS, Tantular IS, Listiawan MY, Hidayati AN, Ervianti E, et al. Association between etiologic species with CD4 count and clinical features of oral candidiasis among HIV / AIDS patients. J Egypt women dermatol soc 2022; 19(1): 51–7.
Tappuni AR. The global changing pattern of the oral manifestations of HIV. Oral Dis 2020 Sep 1;26(S1):22–7.
Lauritano D, Moreo G, Oberti L, Lucchese A, Di Stasio D, Conese M, et al. Oral Manifestations in HIV-Positive Children: A Systematic Review. Pathogens 2020 Jan 31;9(2):88.
Khoury ZH, Meeks V. The influence of antiretroviral therapy on HIV-related oral manifestations. J Natl Med Assoc 2021 Aug;113(4):449–56.
Challacombe SJ. Global oral inequalities in HIV infection. Oral Dis 2016 Apr;22 Suppl 1:35–41.
Riono P, Challacombe SJ. HIV in Indonesia and in neighbouring countries and its social impact. Oral Dis 2020;26:28–33.
Challacombe SJ. Global inequalities in HIV infection. Oral Dis 2020;26:16–21.
WHO. State of inequality: Tuberculosis, HIV and Malaria [Internet]. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/9789240039445
Pour AH, Salari S, Almani PGN. Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran. Curr Med Mycol 2018;4(4):1.
Awoyeni A, Olaniran O, Odetoyin B, Hassan-Olajokun R, Olopade B, Afolayan D, et al. Isolation and evaluation of Candida species and their association with CD4+ T cells counts in HIV patients with diarrhoea. Afr Health Sci 2017;17(2):322–9.
Gray KL, Kiazolu M, Jones J, Konstantinova A, Zawolo JSW, Gray WH, et al. Liberia adherence and loss-to-follow-up in HIV and AIDS care and treatment: A retrospective cohort of adolescents and adults from 2016–2019. PLOS Glob Public Heal 2022;2(3):e0000198.
Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P, et al. Adherence to antiretroviral therapy for HIV in sub‐Saharan Africa and Asia: a comparative analysis of two regional cohorts. J Int AIDS Soc 2017;20(1):21218.
da Rocha GCT, Fonseca RRS, Oliveira-Filho AB, Ribeiro ALR, de Menezes SAF, Laurentino RV, et al. Evaluation of sociodemographic factors and prevalence of oral lesions in people living with HIV from Cacoal, Rondônia, Amazon region of Brazil. Int J Environ Res Public Health 2022;19(5):2614.
Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya AJ, Lomelí-Martínez MA, Martínez-Salazar SY, Mercado González AE, et al. Oral Manifestations Associated with HIV/AIDS Patients. Medicina (Kaunas) 2022 Sep;58(9).
Naidu GS, Thakur R, Singh AK, Rajbhandary S, Mishra RK, Sagtani A. Oral lesions and immune status of HIV infected adults from eastern Nepal. J Clin Exp Dent 2013;5(1):e1.
Subramaniam P, Kumar K. Oral mucosal lesions and immune status in HIV‐infected Indian children. J Oral Pathol Med 2015;44(4):296–9.
Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci 2011;53(2):203–11.
Nanteza M, Tusiime JB, Kalyango J, Kasangaki A. Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital. BMC Oral Health 2014;14(1):1–6.
Du X, Xiong H, Yang Y, Yan J, Zhu S, Chen F. Dynamic study of oral Candida infection and immune status in HIV infected patients during HAART. Arch Oral Biol 2020; 115:104741.
Mounika R, Nalabolu GK, Pallavi N, Birajdar SS. Association of oral candidal species with human immunodeficiency virus patients of West Godavari district, Andhra Pradesh - An in vitro study. J Oral Maxillofac Pathol 2021;25(1):147–53.
Ambe NF, Longdoh NA, Tebid P, Bobga TP, Nkfusai CN, Ngwa SB, et al. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon. Pan Afr Med J 2020;36(1).
Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol 2015;6:1391.
Murtiastutik D, Maharani CS. Profile of Candida Resistancy to Fluconazole in Male Patient with Oral Candidiasis and HIV/AIDS. J AIDS Clin Res 2019;10(3):1–6.
Copyright (c) 2025 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
